| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/10/2007 | CN1893972A Listeria-based EphA2 vaccines |
| 01/10/2007 | CN1893971A A method for increasing CD8<+> cytotoxic T cell reponses and for treating multiple sclerosis |
| 01/10/2007 | CN1893970A Beta-amyloid-analogue-cell epitop vaccine |
| 01/10/2007 | CN1893966A Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 01/10/2007 | CN1893925A In vivo targeting of dendritic cells |
| 01/10/2007 | CN1891829A Alpha (1,3) galactosyl transferase recombinant vector, virosome and its preparation and use |
| 01/10/2007 | CN1891825A Gene and protein relating to hepatocellular carcinoma |
| 01/10/2007 | CN1891716A No mitogen activity anti CD3 small molecular antibody designing method |
| 01/10/2007 | CN1891715A Inhibition of viral infection using monovalent antigen-binding proteins |
| 01/10/2007 | CN1891713A Virulence genes and proteins, and their use |
| 01/10/2007 | CN1294269C Adenovirus carrier for specifically killing primary liver cancer cells and its application |
| 01/10/2007 | CN1294268C Recombinant adenovirus vector capable of being duplicated and spread specifically inside tumor cell |
| 01/10/2007 | CN1294264C High molecular weight major outer membrane protein of moraxella |
| 01/10/2007 | CN1294179C Anti-microbial and -oxidative copolymer |
| 01/10/2007 | CN1294148C Single-stranded cyctic trispecific antibody |
| 01/10/2007 | CN1294143C Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 01/10/2007 | CN1293919C Application of short corynebacteria pharmaceutics or non-cell short corynebacteria pharmaceutics in preparing medicine of treating HIV infection or AIDS |
| 01/10/2007 | CN1293918C Preparation of clostridium welchil toxoid vaccine and antitoxin serum |
| 01/10/2007 | CN1293917C DNA vaccine against proliferating endothelial cells and application thereof |
| 01/10/2007 | CN1293876C New use of 1,3-propylene glycol derivative |
| 01/09/2007 | US7161031 Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders |
| 01/09/2007 | US7160990 Immunoglobulin for use in detection and prevention staphylococcus infections |
| 01/09/2007 | US7160987 Administering a monoclonal antibodie, that bind specifically to one or more preselected CD45R leukocyte antigens, including CD45RB epitope for prevention or reversal of transplant rejection or therapy of autoimmune diseases |
| 01/09/2007 | US7160985 For therapy of diabetes |
| 01/09/2007 | US7160870 Thrombopoietin mimetics |
| 01/09/2007 | US7160869 Biologically active metal-containing nucleic acids |
| 01/09/2007 | US7160859 administering compounds/agents that inhibit Mst1 or the Mst1 kinase pathway such as Caspase 3 inhibitors; assay system for screening potential compounds or agents effective to modulate Mst1 activity; transgenic animal wherein Mst1 expression or activity is enhanced |
| 01/09/2007 | US7160858 induce apoptosis in endothetial cells; binding to annexins; anticancer agents, vuision defects, rheumatic diseases , antidiabetic agents |
| 01/09/2007 | US7160856 Such as alpha-O-linked glycopeptides with clustered glycodomains which are useful as anticancer agents |
| 01/09/2007 | US7160721 Cell culture for use treatment of viral diseases |
| 01/09/2007 | US7160716 Device for inducing an immune response in cancer therapy |
| 01/09/2007 | US7160699 Biosynthesis of botulinium toxins by anaerobic fermentation of Clostridium botulin toxins |
| 01/09/2007 | US7160686 Immunizing a rat with a suspension of fetal cells from the same genetic line, recovering spleen cells, separating lymphocytes, immunizing a second time with the lymphocyte suspension, recovering the antiserum, adding kidney, lung and liver cells, filtration; immunoassay |
| 01/09/2007 | US7160685 Peptides having SEQ ID NO: 2 with immunogenic epitopes activating CD8+ class I major histocompatibility complex restricted cytotoxic T-lymphocytes for patients harboring latent HCMV infection in the absence of active viral replication; using enriched antigen presenting cells; vaccines |
| 01/09/2007 | US7160549 including siderophore receptor polypeptides and porins from gram negative microbes, and preferably, lipopolysaccarhide at a concentration of no greater than about 10.0 endotoxin units per milliliter |
| 01/09/2007 | US7160548 Genetic engineering; screening for tuberculosis |
| 01/09/2007 | US7160547 Comprising a pharmaceutically acceptable carrier and a peptide immunogen for eliciting an immune response in a subject and having at least one streptolysin S epitope |
| 01/09/2007 | US7160546 Immunizing an animal with a polypeptide; recovering an antibody which binds polypeptide |
| 01/09/2007 | US7160545 Useful for treatment and prevention of prostate cancer; is recognized by cytotoxic T lymphocytes |
| 01/09/2007 | US7160544 Method of vaccinating vertebrates |
| 01/09/2007 | US7160543 Tumor necrosis factor nucleic acid; antiinflammatory agents, autoimmune disease, viricides, parasiticides, central nervous system disorders; anti-TNF peptides inhibit and/or neutralize epitopes of human tumor necrosis factor-alpha |
| 01/09/2007 | US7160542 Method of treating psoriasis using human anti-TNF antibodies and fragments |
| 01/09/2007 | US7160541 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 01/09/2007 | US7160539 Altering T cell mediated immunity comprising altering local extracellular concentrations of tryptophan and tryptophan metabolites |
| 01/09/2007 | CA2364617C Method for the reductive amination of polysaccharides |
| 01/09/2007 | CA2327107C Novel recombinant baculovirus, construction method thereof and insect pesticidal composition containing the same |
| 01/09/2007 | CA2309790C Bacterial vaccines comprising auxotrophic, attenuated strains of listeria expressing heterologous antigens |
| 01/09/2007 | CA2269097C Synthesis and purification of hepatitis c virus-like particles |
| 01/09/2007 | CA2263129C Mammalian cell surface antigens; related reagents |
| 01/09/2007 | CA2245099C Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer |
| 01/09/2007 | CA2232325C Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
| 01/09/2007 | CA2194352C Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown |
| 01/09/2007 | CA2141454C Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them |
| 01/04/2007 | WO2007002905A1 Antibody-immune cell ligand fusion protein for cancer therapy |
| 01/04/2007 | WO2007002836A2 Methods and compositions for the prevention and treatment of kidney disease |
| 01/04/2007 | WO2007002793A2 Chimeric sindbis-eastern equine encephalitis virus and uses thereof |
| 01/04/2007 | WO2007002638A1 Anti-marinobufagenin antibodies and methods for their use |
| 01/04/2007 | WO2007002571A2 Use of an anti c5 complement antibody to treat patients with sickle cell disease |
| 01/04/2007 | WO2007002534A2 Thrombospondin-1 derived peptides and treatment methods |
| 01/04/2007 | WO2007002482A1 Method for identifying modulators of rufy2 useful for treating alzheimer's disease |
| 01/04/2007 | WO2007002470A2 Inactivated chimeric vaccines and related methods of use |
| 01/04/2007 | WO2007002465A2 Stabilizing alkylglycoside compositions and methods thereof |
| 01/04/2007 | WO2007002362A2 A direct drug delivery system based on thermally responsive biopolymers |
| 01/04/2007 | WO2007002149A2 Methods and compositions relating to a vaccine against prostate cancer |
| 01/04/2007 | WO2007002018A2 Chimerac tbp-toxin proteins as mucosal adjuvants for vaccination against neisseriae |
| 01/04/2007 | WO2007001915A2 Methods and devices for removing pathogens and detrimental substances from bodily fluids |
| 01/04/2007 | WO2007001851A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/04/2007 | WO2007001487A2 Modulation of negative immune regulators and applications for immunotherapy |
| 01/04/2007 | WO2007001422A2 High affinity antibodies against hmgb1 and methods of use thereof |
| 01/04/2007 | WO2007001361A2 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 01/04/2007 | WO2007001302A1 Delivery of active proteins to the central nervous system using phage vectors |
| 01/04/2007 | WO2007001200A1 Mature dendritic cells loaded with tumor polylysates and antitumoral vaccine base thereon |
| 01/04/2007 | WO2007000935A1 Peptide derived from prostate-related protein as cancer vaccine candidate for prostate cancer patient who is positive for hla-a3 super-type allele molecule |
| 01/04/2007 | WO2007000924A1 Pharmaceutical composition comprising substance capable of inhibiting or promoting progranulin activity and screening method for substance capable of inhibiting or promoting progranulin activity |
| 01/04/2007 | WO2007000884A1 Prophylactic/therapeutic agent for bone/joint disease and screening method for the agent |
| 01/04/2007 | WO2007000671A2 Anti-cd71 monoclonal antibodies and uses thereof for treating malignant tumour cells |
| 01/04/2007 | WO2007000343A2 Process for manufacturing vaccines |
| 01/04/2007 | WO2007000342A2 Immunogenic composition |
| 01/04/2007 | WO2007000341A2 Immunogenic composition |
| 01/04/2007 | WO2007000328A1 Antibodies that bind to an epitope on insulin-like growth factor 1 receptor and uses thereof |
| 01/04/2007 | WO2007000327A1 Immunogenic composition |
| 01/04/2007 | WO2007000322A1 Immunogenic composition |
| 01/04/2007 | WO2007000314A2 Immunogenic composition |
| 01/04/2007 | WO2006124700A3 P53 vaccines for the treatment of cancers |
| 01/04/2007 | WO2006124630A3 Compositions and methods for enhancing the efficacy of vaccines |
| 01/04/2007 | WO2006121656A3 Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease |
| 01/04/2007 | WO2006116319A3 Reagents that bind ccx-ckr2 |
| 01/04/2007 | WO2006097914A3 Compositions of hsp60 peptides and viral antigens for vaccination and diagnosis |
| 01/04/2007 | WO2006074891A3 Proteins containing regulatory t-cells for the therapy and diagnosis of illnesses |
| 01/04/2007 | WO2006073493A3 Vaccine conjugates comprising a monoclonal antibody binding to human dentritic cells and beta human chronic gonadotropin |
| 01/04/2007 | WO2006065894A3 Methods for inhibiting stat3 signaling in immune cells |
| 01/04/2007 | WO2006063329A3 Enhanced protection against mycobacterium tuberculosis |
| 01/04/2007 | WO2006063150A3 Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer |
| 01/04/2007 | WO2006044366A3 E2-epf5, a novel therapeutic protein and target |
| 01/04/2007 | WO2006042313A3 Egfr antagonist in treatment of fluid accumulation |
| 01/04/2007 | WO2006038027A3 SINGLE DOMAIN ANTIBODIES AGAINST TNFRl AND METHODS OF USE THEREFOR |
| 01/04/2007 | WO2006033702A3 Anti-cd154 antibodies |
| 01/04/2007 | WO2006029369A3 Methods and compositions for measuring natriuretic peptides and uses thereof |
| 01/04/2007 | WO2006029338A3 Modified hiv-1 envelope proteins |
| 01/04/2007 | WO2006017824A3 Igf-bp3-related methods for inhibiting tumor growth |